Skip to content
Study details
Enrolling now

Fasting Mimicking Diet for Reducing Immune Related Adverse Events for Cancer Patients on Immune Checkpoint Inhibitors, FMD-ICI Trial

Mayo Clinic
NCT IDNCT06438588ClinicalTrials.gov data as of Apr 2026
Target enrollment

10

Study length

about 3 years

Ages

18+

Locations

1 site in FL

What this study is about

This trial is testing a fast mimicking diet (FMD) to reduce side effects from cancer treatments in patients taking immune checkpoint inhibitors. The FMD involves eating a special diet that mimics fasting and helps protect against common side effects like skin rash, diarrhea, and fatigue.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Dietary Intervention
  • 2.Educational Intervention
  • 3.Electronic Health Record Review
  • +3 more

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
All receive treatment

Everyone gets the investigational treatment.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Endpoints

Primary: Incidence of adverse events, Physical function, Quality of life - FACT-G, Symptom Measurement

Procedures

diagnostic